“Personalised breast screening is the way ahead and has the potential to significantly reduce breast cancer deaths,” said researcher Tony Howells, professor of breast cancer at Manchester University.
Nearly 1,000 women a month die from breast cancer in the UK.
A recent study found that the personalised breast cancer test “substantially improved the accuracy of risk prediction” in women.
“This will allow medics to provide more personalised prevention and early-detection…it has the potential to bring cost savings to the NHS,” said lead researcher Professor Gareth Evans, of the University of Manchester.
The findings are published in JAMA Oncology Journal.